Atlas Trials

CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL

Clinical trial NCT04877080 · WITHDRAWN

Trial details

NCT number
NCT04877080
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Lymphoma
Start date
2021-05-05
Primary completion
2023-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.